Darbepoetin Alfa In Polysorbat
Brand name: Aranesp
Rank #429 of 500 drugs by total cost
$19.3M
Total Cost
6,889
Total Claims
$19.3M
Total Cost
196
Prescribers
$2,806
Cost per Claim
915
Beneficiaries
7,043
30-Day Fills
$99K
Avg Cost/Provider
35
Avg Claims/Provider
About Darbepoetin Alfa In Polysorbat
Darbepoetin Alfa In Polysorbat (sold as Aranesp) was prescribed 6,889 times by 196 Medicare Part D providers in 2023, costing the program $19.3M. At $2,806 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 426 | Fluorouracil (Fluorouracil) | $19.5M | 220,445 |
| 427 | Ertapenem Sodium (Ertapenem) | $19.4M | 36,784 |
| 428 | Sumatriptan Succinate (Sumatriptan Succinate) | $19.4M | 555,011 |
| 429 | Darbepoetin Alfa In Polysorbat (Aranesp) | $19.3M | 6,889 |
| 430 | Ondansetron Hcl (Ondansetron Hcl) | $19.3M | 1,255,548 |
| 431 | Tasimelteon (Hetlioz) | $19.3M | 763 |
| 432 | Isavuconazonium Sulfate (Cresemba) | $19.2M | 3,050 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology